- |||||||||| Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, Enrollment change, Surgery: Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery (clinicaltrials.gov) - May 31, 2016 P1/2, N=33, Completed, Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Mar 2013 Recruiting --> Completed | N=45 --> 33
- |||||||||| Enrollment open, Trial initiation date: HX4 SD: Tumor Hypoxia With HX4 PET in Several Diseases (clinicaltrials.gov) - May 25, 2016
P2, N=120, Recruiting, N=45 --> 21 | Suspended --> Terminated; Interim analysis Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> May 2016
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer (clinicaltrials.gov) - May 13, 2016
P1, N=0, Withdrawn, Recruiting --> Completed N=10 --> 0 | Initiation date: Feb 2016 --> May 2016 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2019 --> May 2016
- |||||||||| New P4 trial: RELIEF Europe Study (clinicaltrials.gov) - May 5, 2016
P4, N=100, Recruiting,
- |||||||||| Dexilant (dexlansoprazole) / Takeda
Enrollment closed, Trial primary completion date: Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease (clinicaltrials.gov) - May 3, 2016 P4, N=300, Active, not recruiting, Initiation date: Jul 2011 --> Nov 2004 | Trial primary completion date: Jun 2029 --> Jul 2010 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Jun 2016
- |||||||||| Biomarker, Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease (clinicaltrials.gov) - May 3, 2016
P=N/A, N=75, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Jun 2016 Recruiting --> Completed | N=156 --> 75 | Initiation date: Oct 2013 --> Mar 2013 | Trial primary completion date: Jun 2015 --> Aug 2014
- |||||||||| Enrollment open, Trial primary completion date: The Captivator EMR Registry (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=300, Recruiting, Active, not recruiting --> Completed | N=50 --> 39 Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2016 --> Dec 2016
- |||||||||| Biomarker, Enrollment change, Trial termination, Trial primary completion date: Permission to Collect Blood Over Time for Research (clinicaltrials.gov) - Apr 25, 2016
P=N/A, N=104, Terminated, Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2016 --> Dec 2016 N=345 --> 104 | Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Oct 2011; Accrual issues - Low Accrual
- |||||||||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Biomarker, Trial primary completion date, Metastases: Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (clinicaltrials.gov) - Apr 21, 2016 P1, N=70, Active, not recruiting, Enrolling by invitation --> Active, not recruiting Trial primary completion date: Jun 2015 --> Jun 2016
- |||||||||| evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
Enrollment change, Trial withdrawal, Trial primary completion date, Combination therapy: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. (clinicaltrials.gov) - Apr 21, 2016 P1, N=0, Withdrawn, Trial primary completion date: Jun 2015 --> Jun 2016 N=18 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Apr 2016
- |||||||||| cisplatin / Generic mfg., pemetrexed / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Metastases: Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Apr 20, 2016 P1, N=10, Completed, Not yet recruiting --> Recruiting Recruiting --> Completed | N=15 --> 10 | Trial primary completion date: Dec 2013 --> Apr 2014
- |||||||||| Trial primary completion date: Study to Image the Esophagus Using the OFDI Capsule (clinicaltrials.gov) - Apr 18, 2016
P1, N=54, Recruiting, Trial primary completion date: Jun 2016 --> Jun 2017 Trial primary completion date: Oct 2015 --> Oct 2017
- |||||||||| Enrollment change, Trial termination, Biopsy: WavSTAT (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=47, Terminated, Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jun 2017 N=250 --> 47 | Suspended --> Terminated; Study has been terminated for inadequate results
- |||||||||| Enrollment change, Trial withdrawal: Validity of a New Stroke Dysphagia Screening Tool (clinicaltrials.gov) - Apr 11, 2016
P=N/A, N=0, Withdrawn, Trial primary completion date: Dec 2014 --> Dec 2015 N=18 --> 0 | Recruiting --> Withdrawn
- |||||||||| Trial completion: IMRT Tomotherapy for Esophagus Cancer (clinicaltrials.gov) - Apr 7, 2016
P1, N=26, Completed, N=36 --> 0 | Active, not recruiting --> Withdrawn Active, not recruiting --> Completed
|